#materialscience

Research, development and commercial applications of advanced flexible materials.

Recent Articles

Challenges and Risks in Batch Bioprocessing

In Brief

Batch bioprocessing is the industry standard in biopharmaceutical production. Although the advancements in biomedical technology that have allowed for batch bioprocessing have been invaluable, some aspects of batch bioprocessing come with limits and challenges. 

Read More
 0

Mutual Dependence: Continuous Bioprocessing and Single-Use Systems

In Brief

The rise of continuous biomanufacturing (CBP) is tied to the ascendance of single-use systems (SUS). Single-use disposables enable CBP by providing a high degree of adaptability, reliability, and continuous yield that effective CBP operations require. In response to market trends that prioritize personalized medicines, many companies are gradually substituting their fixed, stainless-steel implementations for adaptable, flexible, and disposable systems.  Single-use disposables presently on the market include disposable sensors, connectors, bioreactors, and more.

Read More
 0

How Recent Innovations to Detectors and Sensors Have Made Continuous Bioprocessing Viable

In Brief

It has been known for some time that continuous bioprocessing would be a useful strategy in biopharmaceutical production, but it was not quite possible on an industrial scale. Recently, advances to detectors and sensors responsible for measuring real-time critical process parameters and essential attributes of quality have made this idea feasible. Currently, there is a dramatic rise in continuous bioprocessing which would have been impossible without such improvements, either at-line or in-line.

Read More
 0

What Does the Implementation of EU-MDR Mean?

 

In Brief

The passing of the EU Medical Device Regulations (EU-MDR) is forcing medical device manufacturers to update their clinical testing practices and reporting mechanisms. The body of regulations that preceded the EU-MDR, the Medical Device Directive (MDD) is, in comparison, less than half the size of the EU-MDR, was passed in 1993, and is outdated to such an extent that it does not even contain formal contingencies for the definition and classification of software used in medical devices.

Read More
 0

Bioprocessing Single-use Technologies - A Primer

In Brief

According to BCC Research, the global single-use technology market will reach over $4.3 billion by 2021. The most significant increase will be in the highly adaptable disposable mixing system segment. Mixing systems are used in every form of biopharmaceutical production as well as through stages of testing. 

Read More
 0